1. Ambulatory Infusion Delivery Device Selection
Outpatient Parenteral Antimicrobial Therapy (OPAT) enables medically stable patients with serious infections (such as osteomyelitis, endocarditis, and complex intra-abdominal infections) to complete multi-week intravenous antibiotic courses in home and community settings. Device selection must balance drug stability, dosing frequency, and ambulatory ergonomics.
Comparative OPAT Delivery Modalities:
- Elastomeric Balloon Pumps (e.g., Homepump Eclipse®): Non-electronic, single-use ambulatory pumps that utilize an internal elastomeric silicone balloon to drive fluid delivery through a micro-orifice flow restrictor. Highly portable with zero battery requirements. Key thermal caveat: Flow rate calibration is standardized at room temperature (22°C / 72°F). Direct skin contact, warming under bedcovers, or cold ambient temperatures alter delivery velocity by approximately 2.5% per 1°C temperature shift. Patients must be educated to keep the pump pouch outside heavy blankets.
- Electronic Ambulatory Microprocessor Pumps (e.g., CADD-Solis®): Multi-therapy programmable cassette pumps capable of delivering complex intermittent schedules (e.g., Ampicillin every 4 hours or Piperacillin-tazobactam as an extended 4-hour infusion). Provide electronic telemetry, pressure occlusion alarms, and air-in-line detection.
- Gravity Infusion with Dial-a-Flow Regulators: Cost-effective for once-daily stable antimicrobials (e.g., Ceftriaxone 2 g), but susceptible to patient manipulation and positional rate alterations; strictly contraindicated for narrow therapeutic index antibiotics (such as Vancomycin or Aminoglycosides).
2. The Standardized SASH Catheter Flushing Protocol
Catheter patency maintenance and the prevention of intraluminal drug precipitate formation rely on the universal implementation of the SASH Flushing Protocol before and after every antimicrobial dose administered through non-valved vascular access devices.
The 4-Step SASH Sequence:
- S — Saline Flush (Pre-Administration): Cleanse the needleless connector with 70% IPA friction scrub for 15 seconds; allow to air dry for 15 seconds. Flush the catheter with 10 mL of preservative-free 0.9% Normal Saline using a pulsatile push-pause technique. Verify free blood return and easy injection with zero resistance.
- A — Administer Medication: Connect the antimicrobial administration set and infuse the prescribed antibiotic dose over the validated duration.
- S — Saline Flush (Post-Administration): Immediately disconnect the medication set. Disinfect the hub and flush with 10 to 20 mL of 0.9% Normal Saline using ten short, rapid 1-to-2 mL push-pause pulses. This turbulent hydrodynamic vortex scours residual antibiotic molecules and intraluminal protein films out of the dead space.
- H — Heparin Lock: For non-valved catheter lines (such as standard central lines or non-valved PICCs), instill 3 to 5 mL of Heparin Lock solution (100 USP Units/mL). Maintain forward thumb pressure on the syringe plunger while closing the line clamp during the final 0.5 mL of injection to achieve a positive-pressure lock and prevent intraluminal blood reflux.
3. Therapeutic Drug Monitoring (TDM) & Nephrotoxicity Surveillance
Patients receiving home OPAT with narrow therapeutic window antibiotics require mandatory weekly laboratory surveillance coordinated by an outpatient infectious disease pharmacist.
| Antimicrobial Agent | Target Pharmacodynamic Index | Laboratory Sampling Timing | Actionable Toxicity Thresholds |
|---|---|---|---|
| Vancomycin | AUC24 / MIC ratio: 400 to 600 mg·h/L (or steady-state trough 15–20 μg/mL for severe MRSA) | Serum trough drawn within 30 minutes prior to the 4th dose; weekly trough and serum creatinine thereafter. | Serum creatinine increase >=0.3 mg/dL or >=50% over baseline indicates acute kidney injury (AKI); trough >20 μg/mL requires immediate dose reduction or interval extension. |
| Gentamicin / Tobramycin | Once-daily extended interval: Peak 16–24 μg/mL; Trough < 1 μg/mL | Trough level drawn 18 to 24 hours post-dose; weekly serum creatinine and vestibular evaluation. | Trough >=1 μg/mL indicates drug accumulation and impending irreversible vestibular ototoxicity or acute tubular necrosis; hold dose immediately. |
| Daptomycin | Weight-based: 6 to 10 mg/kg once daily IV | Weekly serum Creatine Phosphokinase (CPK) and renal panel. | CPK >1,000 U/L (or >5x ULN with symptoms of muscle pain/weakness) warrants immediate discontinuation to prevent acute rhabdomyolysis. |